QUESTRAN Drug Patent Profile
✉ Email this page to a colleague
When do Questran patents expire, and when can generic versions of Questran launch?
Questran is a drug marketed by Bristol Myers and Apothecon and is included in three NDAs.
The generic ingredient in QUESTRAN is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Questran
A generic version of QUESTRAN was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUESTRAN?
- What are the global sales for QUESTRAN?
- What is Average Wholesale Price for QUESTRAN?
Summary for QUESTRAN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Clinical Trials: | 9 |
| DailyMed Link: | QUESTRAN at DailyMed |
Recent Clinical Trials for QUESTRAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre Hospitalier Universitaire de Nice | N/A |
| City of Hope Medical Center | Phase 1 |
| National Cancer Institute (NCI) | Phase 1 |
US Patents and Regulatory Information for QUESTRAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers | QUESTRAN | cholestyramine | POWDER;ORAL | 016640-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | QUESTRAN | cholestyramine | TABLET;ORAL | 073403-002 | Dec 27, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers | QUESTRAN | cholestyramine | POWDER;ORAL | 016640-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | QUESTRAN | cholestyramine | TABLET;ORAL | 073403-001 | Apr 28, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers | QUESTRAN LIGHT | cholestyramine | POWDER;ORAL | 019669-003 | Dec 5, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
